Sponsored Content

Microspheres Help Fill an Unmet Need in Long-Acting Contraceptives

A notable duration gap exists between three months and three years in FDA-approved long-acting contraceptives.

Company Logo

Released By Adare Pharma Solutions

A notable duration gap exists between three months and three years in FDA-approved long-acting contraceptives. Stratμm microsphere technology from Adare Pharma Solutions was used to help develop a contraceptive with a 9-month release profile and help close this gap.

Fill out the form to download the article >>>

Download Sponsored Content Now

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters